论文部分内容阅读
许多资料表明 ,肿瘤血管的多少和预后有关[1] ,参与肿瘤血管生成的正向调节因子很多 ,其中以血管内皮生长因子(ＶＥＧＦ)最受重视。有文献报道ＶＥＧＦ与非小细胞肺癌(ＮＳＣＬＣ)的期别、类型和中位生存期有关。我们通过对 12 7例ＮＳＣＬＣ的ＶＥＧＦ、ＶＥＧＦ受体、微血管?
Many data show that the number of tumor blood vessels and prognosis [1], many of the positive regulators involved in tumor angiogenesis, of which the most important vascular endothelial growth factor (VEGF). It has been reported in the literature VEGF and non-small cell lung cancer (NSCLC) stage, type and median survival. We through the 12 7 cases of NSCLC VEGF, VEGF receptor, microvascular?